ERBB2 and cancer: Breast cancer remains the most frequently diagnosed cancer in women worldwide and the leading cause of cancer-related death, with a significant proportion being of the human epidermal growth factor receptor 2 (HER2)-negative, hormone receptor (HR)-positive subtype (Siegel et al., 2023; Matutino et al., 2018).